The study investigates the levels of α-Klotho, a protein with neuroprotective properties, in patients with Parkinson's Disease (PD) compared to healthy controls.
Results show that PD patients have significantly lower serum α-Klotho levels (0.85 nmol/L) than controls (1.47 nmol/L), with a notable decrease in those with dementia.
The research indicates α-Klotho might be a potential biomarker for PD, but further studies are necessary to validate these results.